Breast firm HumaScan slashes work force

Article

Citing "severe liquidity problems," breast cancer detection firm HumaScan of Cranford, NJ, has laid off most of its work force and is pursuing strategic alternatives that could result in the sale of the company. The firm said it is taking the approach

Citing "severe liquidity problems," breast cancer detection firm HumaScan of Cranford, NJ, has laid off most of its work force and is pursuing strategic alternatives that could result in the sale of the company. The firm said it is taking the approach due to slow sales of its BreastAlert TDS system, which is designed to detect breast pathology by measuring differences in skin temperature in breast tissue.

Sales of BreastAlert TDS began earlier this year, but the product has generated revenues of only $57,000 in the company's most recent quarter (end-June). That has led to a cash-flow shortage at the firm, a situation that has been complicated by the company's declining stock price and generally turbulent conditions on Wall Street.

HumaScan executives said on Nov. 4 that the company has reduced its personnel from 17 employees to four. The company is also seeking additional funding, with the option of selling the firm if necessary.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.